Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 25 June 2025 | Viewed by 756
Special Issue Editor
Interests: IM gastroenterology; hepatology; nonalcoholic fatty liver disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is my pleasure to invite you to contribute to this Journal of Clinical Medicine Special Issue entitled “Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease”. As you know, the incidence and prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is on the rise. Indeed, this condition is afflicting the global population and is projected to become the leading cause of liver transplantation in the next decade or less. Patients with MASLD are suffering from increasingly worse outcomes, making MASLD a significant burden to our patients, the economy, and healthcare systems as a whole.
As the Guest Editor of this Special Issue, I look forward to accepting and publishing articles that highlight novel concepts for MASLD diagnosis and management to increase awareness and optimize management protocols. The journal and I thank you in advance for your contribution.
Dr. Hirsh D. Trivedi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic dysfunction-associated steatotic liver disease
- MASLD
- non-alcoholic fatty liver disease
- NAFLD
- liver disease
- liver fibrosis
- metabolic syndrome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
